COMPONENTS.
Active, inactive. ff.
Citing DrugCentral © 2024. License
INSTRUCTIONS FOR USE SECTION.
Directions for use. zx.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
NDC 72934- 1028-2 BRIMONIDINE TARTRATE USP 0.25% IVERMECTIN USP 1% METRONIDAZOLE USP 1% NIACINAMIDE USP 4%. c.
Citing DrugCentral © 2024. License
ADVERSE REACTIONS SECTION.
Sincerus Florida, LLC. Adverse reactions. s.
Citing DrugCentral © 2024. License